Clinical Trial Update: Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for sirolimus in kidney transplant patients with squamous cell skin carcinoma has been terminated with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Skin Cancer

Drugs mentioned

• Not specified
• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Florida | Conditions: Squamous Cell Skin Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2015-03-03